BiotechTube
Clinical Investigation Specialists

Clinical Investigation Specialists

Gurnee, United States

Clinical Investigation Specialists Inc. (CIS Research) is a privately-held clinical research organization committed to delivering excellence to the global healthcare sector by making new treatment options available to patients. The company operates award-winning research centers in Gurnee, IL and Kenosha, WI, and has established a Pharmacy Fellowship Program to train the next generation of clinical research professionals. Under the leadership of Dr. Eva Agaiby, CIS Research actively conducts trials in cardiometabolic, cardiovascular, and neurological diseases, contributing to the development of groundbreaking therapies, including recent involvement in FDA-approved diabetes and weight loss trials.

cisresearch.com

Private Company

Funding information not available

AI Company Overview

Clinical Investigation Specialists Inc. (CIS Research) is a privately-held clinical research organization committed to delivering excellence to the global healthcare sector by making new treatment options available to patients. The company operates award-winning research centers in Gurnee, IL and Kenosha, WI, and has established a Pharmacy Fellowship Program to train the next generation of clinical research professionals. Under the leadership of Dr. Eva Agaiby, CIS Research actively conducts trials in cardiometabolic, cardiovascular, and neurological diseases, contributing to the development of groundbreaking therapies, including recent involvement in FDA-approved diabetes and weight loss trials.

CardiometabolicCardiovascularNeurologyDermatology

Technology Platform

Operational platform for patient-centered clinical trial execution, including specialized research clinics, patient recruitment systems, regulatory expertise, and a pharmacy fellowship training program.

Opportunities

Growth opportunities include geographic expansion of its clinic network, diversification into additional high-demand therapeutic areas like oncology, forming strategic preferred-site partnerships with large CROs or pharma companies, and leveraging digital health tools for decentralized trial components to access broader patient populations.

Risk Factors

Key risks include dependence on a limited number of pharmaceutical sponsor contracts, challenges in patient recruitment and retention for trials, intense competition from other research sites and large CROs, and regulatory/compliance risks that could damage its reputation and operational standing.

Competitive Landscape

CIS Research competes with other clinical research sites and mid-sized CROs. It differentiates through deep therapeutic expertise in cardiometabolic/neurology trials, strong community integration in Illinois/Wisconsin, an award-winning reputation for quality, and its investment in training through a Pharmacy Fellowship Program.